Cannabidiol (CBD) as a Promising Anti-Cancer Drug

Recently, cannabinoids, such as cannabidiol (CBD) and Δ<sup>9</sup> -tetrahydrocannabinol (THC), have been the subject of intensive research and heavy scrutiny. Cannabinoids encompass a wide array of organic molecules, including those that are physiologically produced in humans, synthesi...

Full description

Bibliographic Details
Main Authors: Emily S. Seltzer, Andrea K. Watters, Danny MacKenzie, Lauren M. Granat, Dong Zhang
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
CBD
Online Access:https://www.mdpi.com/2072-6694/12/11/3203
id doaj-005f00dc735d498686eaafc2b6830464
record_format Article
spelling doaj-005f00dc735d498686eaafc2b68304642020-11-25T04:04:33ZengMDPI AGCancers2072-66942020-10-01123203320310.3390/cancers12113203Cannabidiol (CBD) as a Promising Anti-Cancer DrugEmily S. Seltzer0Andrea K. Watters1Danny MacKenzie2Lauren M. Granat3Dong Zhang4Department of Biomedical Sciences, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, New York, NY 11568, USADepartment of Biomedical Sciences, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, New York, NY 11568, USADepartment of Biomedical Sciences, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, New York, NY 11568, USADepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH, 44195, USADepartment of Biomedical Sciences, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, New York, NY 11568, USARecently, cannabinoids, such as cannabidiol (CBD) and Δ<sup>9</sup> -tetrahydrocannabinol (THC), have been the subject of intensive research and heavy scrutiny. Cannabinoids encompass a wide array of organic molecules, including those that are physiologically produced in humans, synthesized in laboratories, and extracted primarily from the <i>Cannabis sativa</i> plant. These organic molecules share similarities in their chemical structures as well as in their protein binding profiles. However, pronounced differences do exist in their mechanisms of action and clinical applications, which will be briefly compared and contrasted in this review. The mechanism of action of CBD and its potential applications in cancer therapy will be the major focus of this review article.https://www.mdpi.com/2072-6694/12/11/3203CannbinoidsCannabidiolCBDanti-cancer drug
collection DOAJ
language English
format Article
sources DOAJ
author Emily S. Seltzer
Andrea K. Watters
Danny MacKenzie
Lauren M. Granat
Dong Zhang
spellingShingle Emily S. Seltzer
Andrea K. Watters
Danny MacKenzie
Lauren M. Granat
Dong Zhang
Cannabidiol (CBD) as a Promising Anti-Cancer Drug
Cancers
Cannbinoids
Cannabidiol
CBD
anti-cancer drug
author_facet Emily S. Seltzer
Andrea K. Watters
Danny MacKenzie
Lauren M. Granat
Dong Zhang
author_sort Emily S. Seltzer
title Cannabidiol (CBD) as a Promising Anti-Cancer Drug
title_short Cannabidiol (CBD) as a Promising Anti-Cancer Drug
title_full Cannabidiol (CBD) as a Promising Anti-Cancer Drug
title_fullStr Cannabidiol (CBD) as a Promising Anti-Cancer Drug
title_full_unstemmed Cannabidiol (CBD) as a Promising Anti-Cancer Drug
title_sort cannabidiol (cbd) as a promising anti-cancer drug
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-10-01
description Recently, cannabinoids, such as cannabidiol (CBD) and Δ<sup>9</sup> -tetrahydrocannabinol (THC), have been the subject of intensive research and heavy scrutiny. Cannabinoids encompass a wide array of organic molecules, including those that are physiologically produced in humans, synthesized in laboratories, and extracted primarily from the <i>Cannabis sativa</i> plant. These organic molecules share similarities in their chemical structures as well as in their protein binding profiles. However, pronounced differences do exist in their mechanisms of action and clinical applications, which will be briefly compared and contrasted in this review. The mechanism of action of CBD and its potential applications in cancer therapy will be the major focus of this review article.
topic Cannbinoids
Cannabidiol
CBD
anti-cancer drug
url https://www.mdpi.com/2072-6694/12/11/3203
work_keys_str_mv AT emilysseltzer cannabidiolcbdasapromisinganticancerdrug
AT andreakwatters cannabidiolcbdasapromisinganticancerdrug
AT dannymackenzie cannabidiolcbdasapromisinganticancerdrug
AT laurenmgranat cannabidiolcbdasapromisinganticancerdrug
AT dongzhang cannabidiolcbdasapromisinganticancerdrug
_version_ 1724436264237662208